Abstract

Gamma-LpE (γ-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein (apo) E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-β1-LpA-I, as an initial acceptor of cell-derived cholesterol. In order to further characterize the presence of γ-LpE in human plasma, we have separated γ-LpE by two-dimensional non-denaturing polyacrylamide-gradient gel electrophoresis and detected its presence by immunoblotting with 125I-labeled polyclonal anti-apoE antibody. Five species of γ-LpE were routinely detected in human plasma, ranging in mean particle diameter from 9.5 to 16.5 nm. The largest proportion of γ-migrating apoE was associated with γ2-LpE having a diameter of 13.0 nm. Neither the amount of γ-LpE apoE (representing less than 1–2% of total plasma apoE) nor the number of γ-LpE subfractions was different in serum vs. plasma, or was affected by the presence of agents able to inhibit protein dimerization. γ-LpE subfractions were present in the plasma of patients having different apoE phenotypes (i.e., apoE 2/2, 3/3, or 4/4). Incubation of plasma at 37°C (90 min) caused a significant decrease in plasma γ-LpE (>80%) that was not dependent on LCAT or CETP activity. Storage (at –70°C) of hypertriglyceridemic but not normolipidemic plasma resulted in an increase in γ-LpE. Freezing of postprandial plasma samples, containing increased amounts of triglyceride-rich lipoproteins (TRL) enriched in apoE, also caused an increase in γ-LpE. Incubation of VLDL (d < 1.006 g/ml) with lipase resulted in the production of γ-migrating apoE. These results demonstrate that: 1) different γ-LpE subfractions exist in human plasma; 2) the amount of apoE associated with γ-LpE subfractions is dependent on in vitro conditions of plasma storage; and 3) TRL can act as a source of γ-LpE apoE in vitro.—Krimbou, L., M. Tremblay, H. Jacques, J. Davignon, and J. S. Cohn. In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma. J. Lipid Res. 1998. 39: 861–872.

Highlights

  • Gamma-LpE (␥-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-␤1-LpA-I, as an initial acceptor of cell-derived cholesterol

  • These results demonstrate that: 1) different ␥-LpE subfractions exist in human plasma; 2) the amount of apoE associated with ␥-LpE subfractions is dependent on in vitro conditions of plasma storage; and 3) triglyceride-rich lipoprotein (TRL) can act as a source of ␥-LpE apoE in vitro.—Krimbou, L., M

  • Gamma (␥)-LpE are spherical plasma lipoproteins, 12– 16 nm in diameter, that have ␥-mobility when separated by agarose gel electrophoresis [9, 10]. ␥-LpE are rich in sphingomyelin and apoE and have been proposed to play a role in reverse cholesterol transport by acting, together with pre-␤1-LpA-I, as initial acceptors of cell-derived cholesterol [9, 10]. ␥-LpE and pre-␤1-LpA-I are regarded as antiatherogenic lipoproteins as they have the ability to potentiate the efflux of excess cholesterol from peripheral cells and to mediate the transport of this cholesterol back to the liver for eventual excretion into the bile [12, 13]

Read more

Summary

Introduction

Gamma-LpE (␥-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein (apo) E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-␤1-LpA-I, as an initial acceptor of cell-derived cholesterol. Incubation of VLDL (d Ͻ 1.006 g/ml) with lipase resulted in the production of ␥-migrating apoE These results demonstrate that: 1) different ␥-LpE subfractions exist in human plasma; 2) the amount of apoE associated with ␥-LpE subfractions is dependent on in vitro conditions of plasma storage; and 3) TRL can act as a source of ␥-LpE apoE in vitro.—Krimbou, L., M. of cholesterol from cells by acting as a mediator or acceptor of excess cellular cholesterol [2]. Gamma (␥)-LpE are spherical plasma lipoproteins, 12– 16 nm in diameter, that have ␥-mobility when separated by agarose gel electrophoresis [9, 10]. ␥-LpE are rich in sphingomyelin and apoE and have been proposed to play a role in reverse cholesterol transport by acting, together with pre-␤1-LpA-I (small apoA-I-only-containing HDL), as initial acceptors of cell-derived cholesterol [9, 10]. ␥-LpE and pre-␤1-LpA-I are regarded as antiatherogenic lipoproteins as they have the ability to potentiate the efflux of excess cholesterol from peripheral cells and to mediate the transport of this cholesterol back to the liver for eventual excretion into the bile [12, 13]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call